Recombinant human antibodies specific for hepatitis C virus proteins

Archives of Virology

Volumn 142, Issue 3, 1997, Pages 601-610

  Esposito, G ^a   Morea, V ^a   Scarselli, E ^a   Cerino, A ^b   Mondelli, M U ^b   La Monica, N ^a   Traboni, C ^a  

^a IRBM   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CORE PROTEIN; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; NS3 PROTEIN, HEPATITIS C VIRUS; NS4 PROTEIN, HEPATITIS C VIRUS; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN;

ANTIBODY SPECIFICITY; ARTICLE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN CONFORMATION;

ANTIBODY SPECIFICITY; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS; MAMMALIA; PROKARYOTA;

EID: 0030999033     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050106     Document Type: Article

References (40)

1. Barbas CF, Languino LR, Smith JW (1993) High-affinity self-reactive antibodies by design and selection: targeting the integrin ligand binding site. Proc Natl Acad Sci USA 90: 10003-10007
2. Bernstein FC, Koetzle TF, Williams GJB, Meyer EFJr, Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasumi M (1977) The Protein Data Bank: a computer-based archivial file for macromolecular structures. J Mol Biol 112: 535-542
3. Burioni R, Williamson A, Sanna PP, Bloom FE, Burton DR(1994) Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpex simplex viruses 1 and 2 in vitro. Proc Natl Acad Sci USA 91: 355-359
4. Burton DR, Pyati J, Koduri R, Sharp SJ, Thornton GB, Parren PWHI, Sawyer LSW, Hendry RM, Dunlop N, Nara PL, Lamacchia M, Garratty E, Stiehm ER, Bryson YJ, Cao Y, Moore JP, Ho DD, Barbas CF (1994) Efficient neutralization of primary isolates of HIV-1 by recombinant human monoclonal antibody. Science 266: 1024-1027
5. Cerino A, Mondelli M (1991) Identification of an immunodominant B cell epitope on the HCV nonstructural region defined by human monoclonal antibodies. J Immunol 147: 2092-2096
6. Cerino A, Boender P, La Monica N, Rosa C, Habets W, Mondelli MU (1993) A humanmonoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein. J Immunol 12: 7005-7017
7. Chester KA, Hawkins RE (1995) Clinical issues in antibody design. Tibtech 13: 294-300
8. Chothia C, Novotny J, Bruccoleri R, Karplus M (1985) Domain association in immunoglobulin molecules. J Mol Biol 186: 755-758
9. Chothia C, Lesk AM, Levitt M, Amit AG, Mariuzza RA, Phillips SEV, Poljak RJ (1986) The predicted structure of immunoglobulin D 1.3 and its comparison with the crystal structure. Science 233: 755-758
10. Chothia C, Lesk AM (1987) Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 196: 901-917
11. Chothia C, Lesk AM, Tramontano A, Levitt M, Smith-Gill SJ, Air G, Sheriffs, Padlan EA, Davies D, Tulip WR, Colman PM, Spinelli S, Alzari PM, Poljak RJ (1989) Conformations of immunoglobulin hypervariable regions. Nature 342: 877-883
12. Crowe JE, Murphy BR, Chanock RM, Williamson RA, Barbas CF, Burton DR (1994) Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc Natl Acad Sci USA 91: 1386-1390
13. Dayringer HE, Tramontano A, Sprang SR, Fletterick RJ (1986) Interactive program for visualization and modelling of proteins, nucleic acids and small molecules. J Mol Graph 4: 82-87
14. De Bellis D, Schwartz I (1990) Regulated expression of foreign genes fused to lac:control by glucose levels in growth medium. Nucleic Acids Res 18: 1311
15. De Lalla C, Cerino A, Rosa C, Griva S, Bonelli F, Mondelli MU (1993) Properties of a human monoclonal antibody specific for the NS4 region of hepatitis C virus. J Hepatol 18: 163-167
16. Dueñas M, Borrebaeck CAK (1994) Clonal selection and amplification of phage displayed antibodies by linking antigen recognition and phage replication. Bio/Technology 12: 999-1002
17. Esposito G, Scarselli E, Traboni C (1994) Phage display of a human antibody against Clostridium tetani toxin. Gene 148: 167-168
18. Esposito G, Scarselli E, Cerino A, Mondelli MU, La Monica N, Traboni C (1995) A human antibody specific for hepatitis C virus core protein: synthesis in a bacterial system and characterization. Gene 164: 203-209
19. Genetics Computer Group (1991) Program Manual for the GCG Package, Version 7, April 1991, 575 Science Drive, Madison, Wisconsin, USA 53711
20. Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, Kontermann RE, Jones PT, Low NM, Allison TJ, Prospero TD, Hoogenboom HR, Nissim A, Cox JPL, Harrison JL, Zaccolo M, Gherardi E, Winter G (1994) Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 13: 3245-3260
21. Helmer-Citterich M, Tramontano A (1994) PUZZLE: A new method for automated protein docking based on surface shape complementarity. J Mol Biol 235: 1021-1031
22. Hoogenboom HR, Griffiths AD, Johnson KS, Chiswell DJ, Hudson P, Winter G (1991) Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res 19: 4133-4137
23. Jiang W, Bonnert TP, Venugopal K, Gould EA (1994) A single chain antibody fragment expressed in bacteria neutralizes tick-borne flavivirus. Virology 200: 21-28
24. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C (1992) Sequence of proteins of immunological interest. Distribution files of the V edition, release 5.0. NIH Press, Bethesda
25. Lesk AM (1986) Integrated access to sequence and structural data. In: Saccone C (ed) Biosciences: perspectives and user services in Europe. EEC, Bruxelles, pp 23-28
26. Lesk AM, Tramontano A (1990) Antibody structure and structure predictions useful in guiding antibody engineering. In: Borrcbaeck C (ed) Antibody engineering: a practical guide. IRL Press, Oxford, pp 1-38
27. Light J, Lerner RA (1992) Phophabs: antibody-phage-alkaline phosphatase conjugates for one step ELISA's without immunization. Bioorg Medi Chem Lett 2: 1073-1078
28. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G (1991) By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 222: 581-597
29. Miller JH (1972) Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
30. Mondelli MU, Cerino A, Boender P, Oudshoorn P, Middeldorp J, Fipaldini C, La Monica N, Habets W (1994) Significance of the antibody response to a major discontinuous B cell epitope of the hepatitis C virus NS3 region defined by a human monoclonal antibody. J Virol 68: 4829-4836
31. Mullinax RL, Gross EA, Hay BN, Amberg JR, Kubitz M, Sorge JA (1992) Expression of a heterodimeric Fab antibody protein in one cloning step. Bio/Techniques 12: 864-867
32. Richardson JH, Marasco WA (1995) Intracellular antibodies: development and therapeutic potential. Tibtech 13: 306-310
33. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467
34. Tanaka E, Kiyosawa K, Nakatsuji Y, Inoue Y, Miyamura T, Chiba J, Furuta S (1993) Clinical significance of antibodies to non-structural and core proteins of hepatitis C virus in post-transfusion hepatitis during long term follow up. J Med Virol 39: 6037-6041
35. Tomei L, Failla C, Santolini E, De Francesco R, La Monica N (1993) NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol 67: 4017-4026
36. Van der Poel CL, Cuypcrs HT, Reesink HW(1994) Hepatitis C virus six years on. Lancet 344: 1475-1479
37. Vriend G (1990) WHAT IF: a molecular modeling and drug design program. J Mol Graph 8: 52-56
38. Williamson RA, Burioni R, Sanna PP, Partridge LJ, Barbas CF, Burton DR (1993) Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc Natl Acad Sci USA 90: 4141-4145
39. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR (1994) Making antibodies by phage display technology. Annu Rev Immunol 12: 433-455
40. Zebedee SL, Barbas CF, Horn Y-L, Caothien RH, Graff R, DeGraw J, Pyati J, LaPolla R, Burton DR, Lerner RA, Thornton GB (1992) Human combinatorial antibody libraries to hepatitis B surface antigen. Proc Natl Acad Sci USA 89: 3175-3179